Anavex Life Sciences to Announce Fiscal 2023 Year End Financial Results on Monday, November 27, 2023
Anavex Announces Appointment of Dr Marwan N Sabbagh, MD as Chairman of the Scientific Advisory Board
Anavex Life Sciences Reports Fiscal 2023 Third Quarter Financial Results
Anavex Life Sciences to Present at the BTIG Virtual Biotechnology Conference 2023
Anavex Life Sciences and Partex Group Announce Strategic Partnership
Anavex Life Sciences to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
Anavex Life Sciences Reports Fiscal 2023 Second Quarter Financial Results
Anavex Life Sciences to Announce Fiscal 2023 Second Quarter Financial Resultson Tuesday May 9, 2023
Anavex Life Sciences to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
Anavex Life Sciences to Present at the 22nd Annual Needham Virtual Healthcare Conference 2023
Anavex Life Sciences Reports Fiscal 2023 First Quarter Financial Results
Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on February 7, 2023
Anavex Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022
ANAVEX®2-73 (BLARCAMESINE) PHASE 2B/3 STUDY MET PRIMARY AND KEY SECONDARY ENDPOINTS,
Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update
Anavex Life Sciences to Announce Fiscal 2022 Year End Financial Results on Monday November 28, 2022
Anavex Life Sciences to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
Anavex Life Sciences Announces Late-Breaking Presentation at the 2022 CTAD Congress
Anavex Life Sciences to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
Follow us on social media
